Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Daniel P. Nussbaum(Memorial Sloan Kettering Cancer Center), Kris C. Wood(Duke University), Dylan J. Taatjes(University of Colorado Boulder), Cecilia B. Levandowski(University of Colorado Boulder), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Amy E. Stewart(Duke University), Christian Cerda-Smith(Duke University), Andrew M. Waters(University of North Carolina at Chapel Hill), Shannon J. McCall(Duke Medical Center), Alejandro Barrera(Duke University), J. Joshua Smith(Memorial Sloan Kettering Cancer Center), Channing J. Der(University of North Carolina at Chapel Hill), David E. Kantrowitz(Duke University), Mariaelena Pierobon(George Mason University), Merve Çakır(University of California, San Francisco), Chao Wu(Memorial Sloan Kettering Cancer Center), Justine C. Rutter(Duke University), Annie Liu(Duke University), Colin A. Martz(Duke University), Timothy E. Reddy(Duke University)
Cited by 6
Related Papers
RNA-guided gene activation by CRISPR-Cas9–based transcription factors
|Nature Methods|2013|1.3k
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.1k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k